Regulatory Exposure The firm faced a $20 million settlement related to False Claims Act violations tied to kickbacks. This highlights heightened compliance scrutiny and an opportunity to position enhanced integrity and transparent pricing, payer communication, and risk management services to avoid future penalties.

Specialty Focus As a national specialty pharmacy with a patient-centric model and support services for prescribers, payers, and manufacturers, there is demand for end-to-end programs including patient assistance, adherence support, and provider education to drive refill rates and consistent revenue from specialty therapies.

Growth Readiness Revenue in the mid-range of hundreds of millions indicates scale with room to expand with expanded therapeutic lines, payer partnerships, and value-based contracting. Opportunities exist to offer market access strategies, formulary placement support, and payer negotiation services.

Digital Enablement Current tech stack includes web and frontend tools; there is potential to upsell digital patient engagement platforms, secure data analytics, and omnichannel outreach to improve prescription uptake, adherence, and outcome-driven billing with payers.

Leadership & Expansion With CEO leadership and prior launches of Sub Q products, there is a track record of clinical outreach and product expansion. This points to opportunities in sales enablement, medical liaison programs, and partnerships for new delivery methods or formulary-driven introductions.